PUMA Cancer Research Results
PUMA, p53 upregulated modulator of apoptosis: Click to Expand ⟱
| Source: |
| Type: pro-apoptotic protein |
The expression of PUMA is regulated by the tumor suppressor p53.
PUMA serves as an important proapoptotic factor that functions as a tumor suppressor by facilitating the elimination of damaged or aberrant cells. In many cancers, impaired induction of PUMA—often due to p53 dysfunction—correlates with treatment resistance and aggressive disease.
|
Lung, Lung Cancer: Click to Expand ⟱
Lung CSC (Cancer Stem Cells) markers (CD133, CD44, ALDHA1, Nanog and Oct4)
|
Scientific Papers found: Click to Expand⟱
| - |
in-vitro, |
Lung, |
A549 |
|
|
|
- |
in-vitro, |
Lung, |
PC9 |
|
|
|
AntiCan↑, TumCMig↓, GSH↓, Casp3↑, Apoptosis↑, ROS↑, HDAC1↓, Ac-histone H3↑, PUMA↑, BAX↑, PCNA↓, Bcl-2↓,
Showing Research Papers: 1 to 1 of 1
* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1
Pathway results for Effect on Cancer / Diseased Cells:
Redox & Oxidative Stress ⓘ
GSH↓, 1, ROS↑, 1,
Core Metabolism/Glycolysis ⓘ
Ac-histone H3↑, 1,
Cell Death ⓘ
Apoptosis↑, 1, BAX↑, 1, Bcl-2↓, 1, Casp3↑, 1, PUMA↑, 1,
DNA Damage & Repair ⓘ
PCNA↓, 1,
Proliferation, Differentiation & Cell State ⓘ
HDAC1↓, 1,
Migration ⓘ
TumCMig↓, 1,
Functional Outcomes ⓘ
AntiCan↑, 1,
Total Targets: 12
Pathway results for Effect on Normal Cells:
Total Targets: 0
Scientific Paper Hit Count for: PUMA, p53 upregulated modulator of apoptosis
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include :
-low or high Dose
-format for product, such as nano of lipid formations
-different cell line effects
-synergies with other products
-if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:% IllCat:% CanType:15 Cells:% prod#:% Target#:430 State#:% Dir#:2
wNotes=0 sortOrder:rid,rpid
Home Page